INHIBITORY EFFECT OF KW-3049, A NEW 1, 4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST, ON THE REDUCTION OF MYOCARDIAL CREATINE-KINASE ACTIVITY AND HIGH-ENERGY PHOSPHATE CONTENT IN RATS SUBJECTED TO CORONARY-ARTERY LIGATION

被引:8
作者
KARASAWA, A
KUBO, K
机构
来源
JOURNAL OF PHARMACOBIO-DYNAMICS | 1988年 / 11卷 / 11期
关键词
D O I
10.1248/bpb1978.11.722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:722 / 729
页数:8
相关论文
共 35 条
[1]   EFFECTS OF (-), (+/-), AND (+) VERAPAMIL ON CORONARY OCCLUSION-INDUCED MORTALITY AND INFARCT SIZE [J].
AU, TLS ;
CURTIS, MJ ;
WALKER, MJA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 (03) :327-331
[2]  
BAUER HR, 1984, EUR HEART J S1, V5, P167
[3]   EFFECTS OF A COMBINATION OF METOPROLOL AND DAZMEGREL ON MYOCARDIAL INFARCT SIZE IN RATS [J].
BULLOCK, GR ;
LEPRAN, I ;
PARRATT, JR ;
SZEKERES, L ;
WAINWRIGHT, CL .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (01) :235-240
[4]  
BURKE SE, 1983, ARCH INT PHARMACOD T, V265, P76
[5]   REDUCTION OF CREATINE-KINASE AND CREATINE KINASE-MB INDEXES OF INFARCT SIZE BY INTRAVENOUS VERAPAMIL [J].
BUSSMANN, WD ;
SEHER, W ;
GRUENGRAS, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (10) :1224-1230
[6]   EFFECTS OF PROLONGED ADMINISTRATION OF OXPRENOLOL ON SEVERITY OF ISCHEMIC ARRHYTHMIAS, ENZYME LEAKAGE, INFARCT SIZE, AND INTRACELLULAR CARDIAC-MUSCLE ACTION-POTENTIALS [J].
CAMPBELL, CA ;
PARRATT, JR ;
KANE, KA ;
BULLOCK, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) :369-377
[7]   INFARCT SIZE-REDUCTION - A REVIEW OF THE CLINICAL-TRIALS [J].
CAMPBELL, CA ;
PRZYKLENK, K ;
KLONER, RA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (05) :317-329
[8]   NIFEDIPINE - MYOCARDIAL PROTECTIVE AGENT [J].
CLARK, RE ;
CHRISTLIEB, IY ;
HENRY, PD ;
FISCHER, AE ;
NORA, JD ;
WILLIAMSON, JR ;
SOBEL, BE .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (05) :825-831
[9]   COMPARATIVE EFFECTS OF NICARDIPINE, A NEW CALCIUM-ANTAGONIST, ON SIZE OF MYOCARDIAL-INFARCTION AFTER CORONARY-ARTERY OCCLUSION IN DOGS [J].
ENDO, T ;
NEJIMA, J ;
FUJITA, S ;
KIUCHI, K ;
IIDA, N ;
KIKUCHI, K ;
HAYAKAWA, H ;
OKUMURA, H .
CIRCULATION, 1986, 74 (02) :420-430
[10]  
GROSS R, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1361